Latest Myeloproliferative disease Stories
MPN Research Foundation and The Leukemia & Lymphoma Society Partner to Fund Concept Grants Chicago, IL & White Plains, NY (PRWEB) July 11, 2012
A drug that relieves the severe symptoms of a life-threatening bone marrow cancer called myelofibrosis also improves the survival of patients with the disease.
Walter and Eliza Hall Institute scientists have revealed new details about how cell signalling is controlled in the immune system, identifying in the process potential new therapeutic targets for treating severe blood disorders.
- Large; stout; burly.